Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical characteristics and genetic analysis of a Chinese pedigree of type 2 diabetes complicated with interstitial lung disease. | Front Endocrinol (Lausanne) | 2022 | 36733806 | PubTator, text mining | PubMed |
| Optical Coherence Tomography Retinal Nerve Fibre Layer and Ganglion Cell Complex Measurements in Normal Southern Nigerian Eyes. | Cureus | 2022 | 36726929 | PubTator, text mining | PubMed |
| Association Studies in Clinical Pharmacogenetics. | Pharmaceutics | 2022 | 36678742 | PubTator, text mining | PubMed |
| The Role of Inorganic Phosphate Transporters in Highly Proliferative Cells: From Protozoan Parasites to Cancer Cells. | Membranes (Basel) | 2022 | 36676849 | PubTator, text mining | PubMed |
| Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort. | Atheroscler Plus | 2022 | 36644206 | PubTator, text mining | PubMed |
| Midsize noncoding RNAs in cancers: a new division that clarifies the world of noncoding RNA or an unnecessary chaos? | Rep Pract Oncol Radiother | 2022 | 36632289 | PubTator, text mining | PubMed |
The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake. | Bioinorg Chem Appl | 2022 | 36620349 | PubTator, text mining | PubMed |
| Vericiguat: A New Hope for Heart Failure Patients. | Cardiovasc Ther | 2022 | 36618548 | PubTator, text mining | PubMed |
| Pharmacokinetic Basis for Using Saliva Matrine Concentrations as a Clinical Compliance Monitoring in Antitumor B Chemoprevention Trials in Humans. | Cancers (Basel) | 2022 | 36612086 | PubTator, text mining | PubMed |
| Rescue of Misfolded Organic Cation Transporter 3 Variants. | Cells | 2022 | 36611832 | PubTator, text mining | PubMed |
| Comprehensive molecular analyses of an autoimmune-related gene predictive model and immune infiltrations using machine learning methods in moyamoya disease. | Front Mol Biosci | 2022 | 36605987 | PubTator, text mining | PubMed |
| Organelle-Selective Membrane Labeling through Phospholipase D-Mediated Transphosphatidylation. | JACS Au | 2022 | 36590261 | PubTator, text mining | PubMed |
| Improving the effectiveness of anti-aging modalities by using the constrained disorder principle-based management algorithms. | Front Aging | 2022 | 36589143 | PubTator, text mining | PubMed |
| Research Progress of Population Pharmacokinetic of Metformin. | Biomed Res Int | 2022 | 36578804 | PubTator, text mining | PubMed |
| Current Update on Transcellular Brain Drug Delivery. | Pharmaceutics | 2022 | 36559214 | PubTator, text mining | PubMed |
| Non-Local Mean Denoising Algorithm Based on Fractional Compact Finite Difference Scheme Effectively Reduces Speckle Noise in Optical Coherence Tomography Images. | Micromachines (Basel) | 2022 | 36557339 | PubTator, text mining | PubMed |
| Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and Non-Viral Etiology. | Medicina (Kaunas) | 2022 | 36557005 | PubTator, text mining | PubMed |
| Effects of Metformin Delivery via Biomaterials on Bone and Dental Tissue Engineering. | Int J Mol Sci | 2022 | 36555544 | PubTator, text mining | PubMed |
| Investigations with Drugs and Pesticides Revealed New Species- and Substrate-Dependent Inhibition by Elacridar and Imazalil in Human and Mouse Organic Cation Transporter OCT2. | Int J Mol Sci | 2022 | 36555439 | PubTator, text mining | PubMed |
| Human Breast Milk Contamination with Aflatoxins, Impact on Children's Health, and Possible Control Means: A Review. | Int J Environ Res Public Health | 2022 | 36554670 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=22